Response Biomedical commits to launch timetable:
This article was originally published in Clinica
Executive Summary
Response Biomedical, a Canadian developer of diagnostic tests, told shareholders at its annual general meeting that it was committed to launching its RAMP rapid testing system and a cardiac CK-MB and myoglobin blood tests in Europe and North America next year. The Vancouver, British Columbia-based company is also developing a RAMP PSA test in conjunction with Nippon Kayaku.